Revenue: The sum of all revenue fields included for a company's operating activities.
AbCellera Biologics Inc. (ABCL) had Revenue of $8.96M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$8.96M |
$-57.12M |
|
-- |
|
$8.96M |
|
$85.23M |
|
$-76.28M |
|
$7.51M |
|
$-68.77M |
|
$-68.77M |
|
$-57.12M |
|
$-57.12M |
|
$-57.12M |
|
$-57.12M |
|
$-76.28M |
|
$-69.04M |
|
298.88M |
|
298.88M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$695.14M |
|
$427.36M |
|
$660.85M |
|
$1.36B |
|
$68.80M |
|
-- |
|
$323.15M |
|
$391.95M |
|
$964.04M |
|
$876.91M |
|
$964.04M |
|
299.01M |
|
| Cash Flow Statement Financials | |
$-96.55M |
|
$12.61M |
|
$9.97M |
|
$183.62M |
|
$110.45M |
|
$-73.17M |
|
$42.89M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-851.79% |
|
-851.79% |
|
-- |
|
-767.93% |
|
-637.84% |
|
$-129.48M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.22 |
|
416.64 |
|
-5.92% |
|
-6.51% |
|
-4.21% |
|
-5.92% |
|
$3.22 |
|
$-0.43 |
|
$-0.32 |
|